Ranjan Satish K, Mittal Ankur, Kumar Sunil, Kishore Sanjeev, Narain Tushar A, Mammen Kim J
Department of Urology, AIIMS, Rishikesh, Uttarakhand, India.
Department of Pathology, AIIMS, Rishikesh, Uttarakhand, India.
Indian J Nephrol. 2021 Jul-Aug;31(4):386-389. doi: 10.4103/ijn.IJN_239_20. Epub 2021 Feb 16.
Renal cell carcinoma (RCC) developing in a transplant recipient is about 5-20 times higher than the general population. It is more common in native kidneys than graft kidney, and incidence varies between 0.3% and 4.8%. Clear cell and papillary types are more frequently reported. Most RCC of allograft recipient is usually low-grade with favorable prognosis. We present a case of papillary RCC with sarcomatoid differentiation (SD) in a native kidney of renal transplant (RT) recipient. The coexistence of sarcomatoid variant with papillary RCC, as in our case, makes it a high grade (WHO/ISUP grade 4) and portends a poor prognosis. Relative aggressiveness and rarity of this variant histology in transplant recipients prompted us to report this case and carry out an extensive search of the available literature.
肾移植受者发生肾细胞癌(RCC)的几率比普通人群高约5至20倍。其在自体肾中比移植肾更常见,发病率在0.3%至4.8%之间。透明细胞型和乳头状型报道更为频繁。大多数移植肾受者的RCC通常分级较低,预后良好。我们报告一例肾移植(RT)受者自体肾中发生的具有肉瘤样分化(SD)的乳头状RCC病例。如我们病例中所见,肉瘤样变异型与乳头状RCC并存,使其成为高级别(世界卫生组织/国际泌尿病理学会4级),预后不良。这种变异组织学在移植受者中的相对侵袭性和罕见性促使我们报告此病例并广泛检索现有文献。